全文获取类型
收费全文 | 2389831篇 |
免费 | 181477篇 |
国内免费 | 7265篇 |
专业分类
耳鼻咽喉 | 32584篇 |
儿科学 | 76773篇 |
妇产科学 | 63442篇 |
基础医学 | 351913篇 |
口腔科学 | 64741篇 |
临床医学 | 217308篇 |
内科学 | 460794篇 |
皮肤病学 | 52236篇 |
神经病学 | 186782篇 |
特种医学 | 90004篇 |
外国民族医学 | 523篇 |
外科学 | 358654篇 |
综合类 | 57826篇 |
现状与发展 | 30篇 |
一般理论 | 856篇 |
预防医学 | 185873篇 |
眼科学 | 55646篇 |
药学 | 181205篇 |
75篇 | |
中国医学 | 8305篇 |
肿瘤学 | 133003篇 |
出版年
2021年 | 19834篇 |
2019年 | 21632篇 |
2018年 | 29151篇 |
2017年 | 22468篇 |
2016年 | 24689篇 |
2015年 | 28511篇 |
2014年 | 39477篇 |
2013年 | 57224篇 |
2012年 | 79386篇 |
2011年 | 84318篇 |
2010年 | 50438篇 |
2009年 | 47482篇 |
2008年 | 77940篇 |
2007年 | 82579篇 |
2006年 | 83209篇 |
2005年 | 80439篇 |
2004年 | 76442篇 |
2003年 | 73412篇 |
2002年 | 70826篇 |
2001年 | 109814篇 |
2000年 | 112344篇 |
1999年 | 94016篇 |
1998年 | 26034篇 |
1997年 | 22560篇 |
1996年 | 22876篇 |
1995年 | 23085篇 |
1994年 | 21195篇 |
1993年 | 19895篇 |
1992年 | 72304篇 |
1991年 | 70457篇 |
1990年 | 68731篇 |
1989年 | 65968篇 |
1988年 | 60554篇 |
1987年 | 59364篇 |
1986年 | 55423篇 |
1985年 | 53224篇 |
1984年 | 39389篇 |
1983年 | 33449篇 |
1982年 | 19866篇 |
1979年 | 35919篇 |
1978年 | 25673篇 |
1977年 | 21208篇 |
1976年 | 20318篇 |
1975年 | 21827篇 |
1974年 | 26169篇 |
1973年 | 24829篇 |
1972年 | 23250篇 |
1971年 | 22069篇 |
1970年 | 20286篇 |
1969年 | 19334篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
82.
目的 探讨TRIM23基因对骨肉瘤细胞增殖能力的影响.方法 应用Western blot实验检测TRIM23基因在骨肉瘤细胞中的表达;应用shRNA质粒转染骨肉瘤细胞系U2OS,通过MTT与平板克隆形成实验评估细胞增殖能力;应用Westernblot实验检测U2OS细胞Akt/P53/P21通路的表达改变.结果 TRIM23蛋白在骨肉瘤细胞中的表达高于成骨细胞;沉默TRIM23基因可以抑制骨肉瘤细胞的增殖能力;沉默TRIM23基因下调P-Akt表达,但总Akt的表达无明显改变,上调P53与P21的表达.结论 TRIM23在骨肉瘤细胞中表达升高,TRIM23能通过调节Akt/P53/P21通路影响骨肉瘤细胞的增殖. 相似文献
83.
Immunoglobulin light chain amyloidosis (AL) commonly presents with nephrotic range proteinuria, heart failure with preserved ejection fraction, nondiabetic peripheral neuropathy, unexplained hepatomegaly or diarrhea, and should be considered in patients presenting with these symptoms. More importantly, patients being monitored for smoldering multiple myeloma and a monoclonal gammopathy of undetermined significance (MGUS) are at risk for developing AL amyloidosis. MGUS and myeloma patients that have atypical features, including unexplained weight loss; lower extremity edema, early satiety, and dyspnea on exertion should be considered at risk for light chain amyloidosis. Overlooking the diagnosis of light chain amyloidosis leading to therapy delay is common, and it represents an error of diagnostic consideration. Herein we provide a review of established and investigational treatments for patients with AL amyloidosis and provide algorithms for workup and management of these patients.Subject terms: Myeloma, Chemotherapy 相似文献
84.
85.
86.
Abd-Allah H. El Ashmawy Kathleen Dowson Ahmed El-Bakoury Hazem A.H. Hosny Rathan Yarlagadda Jonathan Keenan 《The Journal of arthroplasty》2021,36(3):816-822.e1
BackgroundTotal hip and knee arthroplasties are increasingly performed operations, and routine follow-up places huge demands on orthopedic services. This study investigates the effectiveness, patients’ satisfaction, and cost reduction of Virtual Joint Replacement Clinic (VJRC) follow-up of total hip arthroplasty and total knee arthroplasty patients in a university hospital. VJRC is especially valuable when in-person appointments are not advised or feasible such as during the COVID-19 pandemic.MethodsA total of 1749 patients who were invited for VJRC follow-up for knee or hip arthroplasty from January 2017 to December 2018 were included in this retrospective study. Patients were referred to VJRC after their 6-week postoperative review. Routine VJRC postoperative review was undertaken at 1 and 7 years and then 3-yearly thereafter. We evaluated the VJRC patient response rate, acceptability, and outcome. Patient satisfaction was measured in a subgroup of patients using a satisfaction survey. VJRC costs were calculated compared to face-to-face follow-up.ResultsThe VJRC had a 92.05% overall response rate. Only 7.22% required further in-person appointments with only 3% being reviewed by an orthopedic consultant. VJRC resulted in an estimated saving of £42,644 per year at our institution. The patients’ satisfaction survey showed that 89.29% of the patients were either satisfied or very satisfied with VJRC follow-up.ConclusionVJRC follow-up for hip and knee arthroplasty patients is an effective alternative to in-person clinic assessment which is accepted by patients, has high patient satisfaction, and can reduce the cost to both health services and patients. 相似文献
87.
88.
89.
90.
Pauline A. J. Mendelaar Jaco Kraan Mai Van Leonie L. Zeune Leon W. M. M. Terstappen Esther Oomende Hoop John W. M. Martens Stefan Sleijfer 《Molecular oncology》2021,15(1):116
Circulating tumor cells (CTCs) in the blood of cancer patients are of high clinical relevance. Since detection and isolation of CTCs often rely on cell dimensions, knowledge of their size is key. We analyzed the median CTC size in a large cohort of breast (BC), prostate (PC), colorectal (CRC), and bladder (BLC) cancer patients. Images of patient‐derived CTCs acquired on cartridges of the FDA‐cleared CellSearch® method were retrospectively collected and automatically re‐analyzed using the accept software package. The median CTC diameter (μm) was computed per tumor type. The size differences between the different tumor types and references (tumor cell lines and leukocytes) were nonparametrically tested. A total of 1962 CellSearch® cartridges containing 71 612 CTCs were included. In BC, the median computed diameter (CD) of patient‐derived CTCs was 12.4 μm vs 18.4 μm for cultured cell line cells. For PC, CDs were 10.3 μm for CTCs vs 20.7 μm for cultured cell line cells. CDs for CTCs of CRC and BLC were 7.5 μm and 8.6 μm, respectively. Finally, leukocytes were 9.4 μm. CTC size differed statistically significantly between the four tumor types and between CTCs and the reference data. CTC size differences between tumor types are striking and CTCs are smaller than cell line tumor cells, whose size is often used as reference when developing CTC analysis methods. Based on our data, we suggest that the size of CTCs matters and should be kept in mind when designing and optimizing size‐based isolation methods.
Abbreviations
- ACCEPT
- Automated CTC Classification, Enumeration, and PhenoTyping software
- BC
- breast cancer
- BLC
- bladder cancer
- CD
- computed diameter
- CEL
- cultured tumor cell (cell line)
- CK
- cytokeratin
- CRC
- colorectal cancer
- CTC‐L
- circulating tumor cells derived from cerebrospinal fluid (liquor)
- CTCs
- circulating tumor cells
- DAPI
- 4′6‐diamidino‐2‐phenylindole
- EMT
- epithelial–mesenchymal transition
- EpCAM
- epithelial cell adhesion molecule
- IQR
- interquartile range
- KW test
- Kruskal–Wallis test
- MWU test
- Mann–Whitney U test
- NCR
- nucleus/cytoplasm ratio
- P2A
- perimeter to area
- PC
- prostate cancer
- TIF
- tagged Image Format files
- TXT
- text file
- μm
- micrometer
- µm2
- square micrometers